10 min read

How Clinical Trials Work: Understanding GLP-1 Study Data

Every FDA-approved drug has been through a multi-phase clinical trial program.

10 min read

CJC-1295 + Ipamorelin Stack: The Most Popular GH Protocol Explained

The CJC-1295 plus ipamorelin combination is probably the most prescribed peptide stack in US wellness and anti-aging clinics.

9 min read

CJC-1295: Can You Stack It with GLP-1 Medications?

Introduction Patients on semaglutide or tirzepatide sometimes ask whether adding CJC-1295 would preserve lean mass during weight loss or accelerate body composition improvements. The…

11 min read

CJC-1295 What the Research Actually Says: Evidence Review

CJC-1295 has been in the peptide therapy conversation since the mid-2000s, but the published human evidence base is surprisingly small.

9 min read

CJC-1295 How It Works: Mechanism of Action Explained Simply

Introduction CJC-1295 is a modified version of growth hormone releasing hormone (GHRH), the natural signal your hypothalamus sends to the pituitary gland to release…

8 min read

CJC-1295 Dosing Protocol: Cycling, Frequency & Best Practices

CJC-1295 dosing varies dramatically between published clinical trials and the protocols sold by compounding pharmacies and anti-aging clinics.

11 min read

CJC-1295 Complete Guide: Benefits, Dosing, Side Effects & Research

Introduction CJC-1295 is a synthetic analog of growth hormone releasing hormone (GHRH) that extends the half-life of natural GHRH from about 7 minutes to…

11 min read

The Circadian Clock and Metabolism: Why Meal Timing Matters on GLP-1

Your liver, your fat cells, and your pancreas all have their own clocks.

10 min read

What to Do When Cigna Denies Zepbound: Step-by-Step Appeal

Cigna runs pharmacy benefits through Express Scripts, which means Zepbound denials come back as Express Scripts adverse determination letters.

Stay on Track

Join our community and receive:
Expert tips on maximizing your GLP-1 treatment.
Exclusive discounts on your next order.
Updates on the latest weight-loss breakthroughs.